Solid Impact Investments Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Itamar David
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.5yrs |
| CEO ownership | 53.3% |
| Management average tenure | no data |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO
Itamar David (44 yo)
3.5yrs
Tenure
Mr. Itamar David has been Chief Financial officer of Enox Biopharma, Inc. since July 23, 2009. Mr. David has been self-employed as a consultant to private and public companies since August 2006. Mr. David...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 3.5yrs | no data | 53.33% CA$ 80.0k | |
| Independent Director | 3.3yrs | no data | 3.33% CA$ 5.0k | |
| Independent Director | 3.3yrs | no data | 16.67% CA$ 25.0k | |
| Director | 3.3yrs | no data | 6.67% CA$ 10.0k |
3.3yrs
Average Tenure
Experienced Board: SOLI.P's board of directors are considered experienced (3.3 years average tenure).